Alpha Hormones expressly refers to FDA-approved oral micronized progesterone in its hormone-care information. That is a meaningful description: it connects regulatory status, route and a formulation term. It is still a provider statement about an option, rather than confirmation that a particular patient will receive an identified product from a particular manufacturer.
We reviewed Alpha’s BHRT, pricing and subscription-policy pages on September 29, 2026. This review considers how far the approved-oral wording can be taken, what is still missing from the medicine record and how the service is purchased. Alpha’s published geography is limited, and its recurring payment should not be confused with automatic prescription renewal.
Read this article by section
The specific oral claim is stronger than a generic hormone menu
Alpha’s BHRT page identifies an FDA-approved oral micronized progesterone option while discussing compounded choices separately. The distinction should be retained. It would be inaccurate either to call every option compounded or to apply the approval language to everything the practice offers. The page does not identify the manufacturer or package of an individual prescription. Our Fountain review concerns a kit description with less preparation detail. That comparison shows why the wording matters, but it does not establish that Alpha is clinically superior or that its listed option is appropriate for any particular person.
Approved generic status involves more than matching the active ingredient
FDA’s generic-drug questions and answers explains the requirements connecting an approved generic with its reference medicine, including strength, dosage form, route and bioequivalence. A provider’s statement about an approved category should ultimately lead to an identifiable product record. The bioidentical approval guide keeps that regulatory question separate from chemical identity. Alpha’s public description alone does not demonstrate which approved product would be selected or whether the clinician would propose a different category for a particular reason. Ask for the exact medicine name before attaching a manufacturer’s patient information or evidence to the proposal.
An excipient check is narrower than a class-wide warning
The exact Prometrium label includes peanut oil and product-specific allergy restrictions. FDA also explains that approved generics can differ in some inactive ingredients. These facts make the actual formulation important; they do not identify the contents of an unknown Alpha prescription. A pharmacist should answer an ingredient concern from the supplied product’s information, rather than from the broad category oral micronized progesterone. Our micronized meaning guide explains why the processing term does not reveal every capsule component. We have not authenticated a package, its manufacturer or its ingredient statement through the practice.
The published access map is not nationwide
Alpha’s pricing and access page describes in-person care in Pasadena and telehealth for residents of California, Texas and Florida. Those limits belong beside the clinical offer. A reader outside those locations cannot assume eligibility from the availability of an online booking page. The page also lists insurance categories and exclusions, while making the patient responsible for uncovered amounts and requiring benefits confirmation. Neither an insurer’s name nor an approved medicine category proves personal coverage. The service should confirm the relevant clinician, location rules and payment arrangement before a prospective patient treats the published offer as available to them.
Read the starting membership figure with the setup charge and visit unit
The women’s pricing description starts at $349 per month or $3,490 per year and lists a $200 one-time enrollment charge. It describes consultations, tailored testing, prescriptions and supplies with shipping, while allowing additional out-of-pocket services. The subscription policy further limits each month after the first to one fifteen-minute telehealth or in-person consultation. That unit belongs beside the inclusion claim. These are membership terms, not the standalone price of a particular progesterone capsule. Ask for the selected plan’s complete inclusions and exclusions, including any medicine or service that would be charged separately. The pricing page names several hormones within the women’s program. That list does not mean every member receives every listed medicine, nor that each proposed item has the same regulatory status. A written quote should connect the selected charges to the actual clinical proposal. The starting price and annual amount are different payment options, not a capsule count or a treatment duration. This distinction prevents the advertised membership contents from being mistaken for an instruction to obtain a combination of hormones.
Recurring payment and a refill request are not the same event
The policy explains that automatic billing does not automatically request a refill; the patient has a separate request responsibility. It also requires written cancellation notice thirty days before the next billing date, rejects prorated subscription refunds for remaining days and separately addresses prescription returns. Those distinctions should remain visible when assessing ongoing costs. Our Newson Clinic review considers UK consultation fees rather than treating every care relationship as the same subscription model. A clinician still determines prescribing, so payment continuity cannot be used as proof that a medicine will be renewed or remain appropriate.
Keep the approval claim attached to the right object
The practical question for Alpha is which specific approved oral product, if any, is proposed and how its evidence relates to the intended use. The BHRT page provides a category statement; it does not make the entire clinical program FDA approved. FDA’s compounding information remains relevant if a different compounded option is discussed. The route guide also prevents the oral claim from being transferred to another formulation. A complete answer would name the medicine, responsible clinician, pharmacy and selected charges. This review establishes the published category and access terms without resolving individual prescribing or making a comparative safety claim.
Documents behind the details
Read the source for the product, use and context it actually describes. A source type is not a rating of a provider.
- Alpha Hormones: Bioidentical hormone replacement therapyProvider treatment menu naming FDA-approved oral micronized progesterone and separately compounded options; no exact prescribed product confirmed · Checked 2026-09-29
- FDA: Generic Drugs — Questions & AnswersFDA public generic-drug explanation, updated September 18, 2026; approved-generic requirements and qualified inactive-ingredient differences, not identification or substitution advice for a particular provider prescription · Checked 2026-09-29
- FDA: Prometrium progesterone capsules prescribing informationExact FDA product label, reference ID 5744934; ingredients, indications and warnings apply to this product, not all progesterone preparations · Checked 2026-09-29
- Alpha Hormones: PricingProvider program starting prices, setup fee, access and insurance descriptions; individual selection and benefits remain unverified · Checked 2026-09-29
- Alpha Hormones: Subscription cancellation policyProvider recurring billing, refill-request and cancellation/return conditions; attributed purchase policy, not generalized legal advice · Checked 2026-09-29
- FDA: Understanding the Risks of Compounded DrugsFederal primary guidance on compounding and lack of FDA premarket approval; not individual treatment advice · Checked 2026-09-29